Luis Jodar

Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs

New York City, NY

United States

SCHOLARLY PAPERS

5

DOWNLOADS
Rank 11,380

SSRN RANKINGS

Top 11,380

in Total Papers Downloads

7,971

SSRN CITATIONS
Rank 30,350

SSRN RANKINGS

Top 30,350

in Total Papers Citations

37

CROSSREF CITATIONS

0

Scholarly Papers (5)

1.

Six-Month Effectiveness of BNT162B2 mRNA COVID-19 Vaccine in a Large US Integrated Health System: A Retrospective Cohort Study

Number of pages: 40 Posted: 23 Aug 2021
Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente - Southern California Kaiser Permanente Medical Group, Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California, Kaiser Permanente - Southern California Kaiser Permanente Medical Group, Kaiser Permanente - Kaiser Permanente Center for Integrated Health Care Research, Kaiser Permanente Southern California - Department of Research & Evaluation, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs and Pfizer, Inc.
Downloads 5,580 (2,873)

Abstract:

Loading...

2.

Nationwide Vaccination Campaign with BNT162b2 in Israel Demonstrates High Vaccine Effectiveness and Marked Declines in Incidence of SARS-CoV-2 Infections and COVID-19 Cases, Hospitalizations, and Deaths

Number of pages: 24 Posted: 24 Mar 2021
Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Pfizer, Inc., Ministry of Health (Israel) - Public Health Services, Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Ministry of Health (Israel) - Information Technology Department, Ministry of Health (Israel) - Information Technology Department, Pfizer Pharmaceuticals Israel Ltd, Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Harvard University - Center for Communicable Disease Dynamics, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Ministry of Health (Israel) and Ministry of Health (Israel) - Department of Maternal and Child Health
Downloads 1,663 (20,648)
Citation 1

Abstract:

Loading...

COVID-19, SARS-CoV-2, vaccine effectiveness, prevention, mRNA vaccines, pandemic, observational study, epidemiology

3.

Infections, Hospitalizations, and Deaths Averted Via Direct Effects of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine in a Nationwide Vaccination Campaign, Israel

Number of pages: 25 Posted: 13 May 2021
Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Yale UniversityMinistry of Health (Israel) - Public Health Services, Harvard T.H. Chan School of Public Health - Center for Communicable Disease Dynamics, Ministry of Health (Israel) - Public Health Services, Pfizer Pharmaceuticals Israel Ltd, Ministry of Health (Israel) - Information Technology Department, Ministry of Health (Israel) - Information Technology Department, Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Harvard University - Center for Communicable Disease Dynamics, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Ministry of Health (Israel) and Ministry of Health (Israel) - Department of Maternal and Child Health
Downloads 467 (116,500)
Citation 1

Abstract:

Loading...

COVID-19, SARS-CoV-2, cases averted, impact, hospitalizations, deaths, Israel, model, public health, pandemic

4.

Effectiveness of BNT162b2 mRNA COVID-19 Vaccine Against SARS-CoV-2 Variant Beta (B.1.351) Among Persons Identified Through Contact Tracing in Israel

Number of pages: 29 Posted: 13 Aug 2021
Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Harvard University - Center for Communicable Disease Dynamics, Pfizer, Inc., Ministry of Health (Israel), Israel Ministry of Health, Yale UniversityMinistry of Health (Israel) - Public Health Services, Sheba Medical Center - Central Virology Laboratory, Sheba Medical Center - Central Virology Laboratory, Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer, Inc., Pfizer Pharmaceuticals Israel Ltd, Harvard T.H. Chan School of Public Health - Center for Communicable Disease Dynamics, Ministry of Health (Israel) - Public Health Services, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Ministry of Health (Israel) and Ministry of Health (Israel) - Department of Maternal and Child Health
Downloads 188 (299,132)
Citation 1

Abstract:

Loading...

5.

County-Level Vaccination Coverage and Rates of COVID-19 Cases and Deaths in the United States

Number of pages: 30 Posted: 20 Aug 2021
Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Harvard University - Center for Communicable Disease Dynamics and Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs
Downloads 73 (597,166)
Citation 3

Abstract:

Loading...